Myoclonic Epilepsy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-01-30
Clinical Trial Update: Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies
Clinical trial update describing an extended access program using lorcaserin to treat Dravet syndrome and other refractory epilepsies.